Invention Grant
- Patent Title: Proteomic IPF markers
-
Application No.: US14213970Application Date: 2014-03-14
-
Publication No.: US09726677B2Publication Date: 2017-08-08
- Inventor: Karl Kossen , Xiaoli Qin , Sharlene R. Lim , Scott S. Seiwert , Donald Ruhrmund
- Applicant: Intermune, Inc.
- Applicant Address: US CA Brisbane
- Assignee: INTERMUNE, INC.
- Current Assignee: INTERMUNE, INC.
- Current Assignee Address: US CA Brisbane
- Agency: Mintz Levin Cohn Ferris Glovsky and Popeo, P.C.
- Main IPC: A61K38/44
- IPC: A61K38/44 ; G01N33/68 ; C12Q1/68
Abstract:
Provided herein are novel biomarkers for the identification, prediction or monitoring of fibrotic pulmonary diseases (e.g. idiopathic pulmonary fibrosis (IPF)). The biomarkers provided herein may further be used for therapeutic treatment of IPF.
Public/Granted literature
- US20140286929A1 PROTEOMIC IPF MARKERS Public/Granted day:2014-09-25
Information query
IPC分类:
